Discontinuation report MOBICOX
| Report ID | 54819 |
| Drug Identification Number | 02242785 |
| Brand name | MOBICOX |
| Common or Proper name | Mobicox 7.5MG |
| Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MELOXICAM |
| Strength(s) | 7.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100s |
| ATC code | M01AC |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-01-01 |
| Actual discontinuation date | 2018-10-31 |
| Remaining supply date | 2018-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Duplicated record |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
| Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-07-09 | English | Compare |
| v2 | 2018-07-09 | French | Compare |
| v3 | 2019-06-10 | English | Compare |
| v4 | 2019-06-10 | French | Compare |
Showing 1 to 4 of 4